Iaten (Meloxicam)

Meloxicam selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, reducing the production of prostaglandins that drive inflammation, pain, and fever, while largely preserving COX‑1 activity that protects the stomach lining.

The exact dose of Iaten is determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for meloxicam in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified health professional.

To order Iaten, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with non‑selective NSAIDs, meloxicam offers a higher degree of COX‑2 selectivity, which may reduce the risk of gastrointestinal irritation while still providing effective analgesic and anti‑inflammatory activity. However, cardiovascular and renal safety considerations remain similar to other NSAIDs.

Iaten should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date.

Iaten is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can help lessen occasional stomach discomfort.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe liver enzyme elevation, acute kidney injury, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice any of these signs.

Iaten is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal bleeding or ulceration, severe heart failure, and patients who have had a recent coronary artery bypass graft. Caution is also advised for patients with impaired renal or hepatic function.